Amring Pharms Company Profile

✉ Email this page to a colleague

AMRING PHARMS has fourteen approved drugs.

There are eight US patents protecting AMRING PHARMS drugs.

There are eight patent family members on AMRING PHARMS drugs in two countries and thirty-one supplementary protection certificates in ten countries.

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amring Pharms	SUCCINYLCHOLINE CHLORIDE	succinylcholine chloride	INJECTABLE;INJECTION	210231-001	Jun 4, 2018	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Amring Pharms	CIPROFLOXACIN HYDROCHLORIDE	ciprofloxacin hydrochloride	SOLUTION/DROPS;OPHTHALMIC	078598-001	Jan 16, 2008		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Amring Pharms	LAMOTRIGINE	lamotrigine	TABLET, ORALLY DISINTEGRATING;ORAL	214124-001	Feb 3, 2022	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Amring Pharms	LYSTEDA	tranexamic acid	TABLET;ORAL	022430-001	Nov 13, 2009	AB	RX	Yes	Yes	8,487,005	⤷ Try a Trial	Y			⤷ Try a Trial
Amring Pharms	LYSTEDA	tranexamic acid	TABLET;ORAL	022430-001	Nov 13, 2009	AB	RX	Yes	Yes	9,060,939	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	650 mg	➤ Subscribe	2011-05-24

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Japan	2011168596	⤷ Try a Trial
Japan	5000504	⤷ Try a Trial
Japan	2008508276	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2006023001	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2006023000	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0364417	97C0128	France	⤷ Try a Trial	PRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718
0364417	97C0111	Belgium	⤷ Try a Trial	PRODUCT NAME: LATANOPROSTUM; NAT. REGISTRATION NO/DATE: 277 IS 271 F 13 19970617; FIRST REGISTRATION: SE 12716 1996071
0509752	SPC/GB99/043	United Kingdom	⤷ Try a Trial	PRODUCT NAME: DORZOLAMIDE OR AN OPHTHALMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY DORZOLAMIDE HYDROCHOLORIDE, PLUS TIMOLOL OR AN OPHTHAMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY TIMOLOL MALEATE; REGISTERED: DK 19045 19980306; UK PL 00025/0373 19980804
3461484	C202130024	Spain	⤷ Try a Trial	PRODUCT NAME: NETARSUDIL O UN ENANTIOMERO, DIASTEREIOISOMERO, SAL O SALVADO DEL MISMO EN COMBINACION CON LATANOPROST O UNA SAL DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/20/1502; DATE OF AUTHORISATION: 20210107; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1502; DATE OF FIRST AUTHORISATION IN EEA: 20210107
1429780	122012000070	Germany	⤷ Try a Trial	PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.